GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Price-to-Funds-From-Operations

NewAmsterdam Pharma Co NV (FRA:KH6) Price-to-Funds-From-Operations : (As of Apr. 10, 2025)


View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


NewAmsterdam Pharma Co NV Business Description

Traded in Other Exchanges
Address
Gooimeer 2-35, Naarden, NH, NLD, 1411 DC
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.